Fact CheckerSign in

NCT04019808Completed

Gastric Cancer Risk Factors Knowledge in European and Latinamerican Population

Interventional Study at the Primary and Secondary Levels of Prevention for Knowledge Regarding GC Risk Factors in EU and CELAC Populations

Source: ClinicalTrials.gov · Last updated 9 May 2024

Brief summary (registry, in English)

This study is divided into two parts: Part 1: An interventional study, with a pre-post study design to determinate the grade of knowledge of established GC risk factors. Part 2: An observational study to know impact on prevalence and infection eradication of H. pylori

Status (registry)
Completed
Study type
Observational
Enrollment
800 (actual)
First submitted
5 Jun 2019
Start date
30 Jul 2019
Primary completion date
31 Dec 2023
Lead sponsor
Fundación para la Investigación del Hospital Clínico de Valencia
NCT number
NCT04019808

What you commit to

  • Study type: Observational
  • Participants enrolled: 800
  • From 30 Jul 2019 to the primary completion date, 31 Dec 2023
  • 8 sites in 7 countries
  • Visits and tests: ask the trial team, the registry does not list them

Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.

Who cannot take part

Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.

Criteria the registry did not label

  • Part A: Educational Intervention Inclusion criteria
  • Subjects \>18 years old, from EU and CELAC countries participating in this study.
  • Has given and signed the IC to participate in this study. Exclusion criteria
  • Subjects who have received some prior preparation (Cancer Gastric Information).
  • Subjects who have previous Knowledge in Gastric Cancer (Example, near relatives who have suffered Gastric Cancer
    • Part B: H. pylori Register Inclusion criteria
  • Subjects ≥18 years old diagnose from H. pylori infection and treated at participant sites
  • Has given and signed the IC. Exclusion criteria
  • Subjects with chronic gastritis without confirmed diagnose of H. pylori infection, pathologically of by urease test.
  • Patient's with CG diagnosis (including gastroesophageal junction cancer).

Age in the registry: 18 years to 90 years · Sex: All

Full criteria on ClinicalTrials.gov

Sites (8)

Sites in registry order. Pick your city on the disease page to sort them by distance.

SiteCityCountrySite status
Instituto Alexander Fleming
Coordinator of this site? Confirm its status
Buenos AiresArgentinaUnknown status
Pontificia Universidad Catolica de Chile
Coordinator of this site? Confirm its status
SantiagoChileUnknown status
Fundació Privada Institut d'Investigació Oncològica de Vall-Hebron (VHIO)
Coordinator of this site? Confirm its status
BarcelonaSpainUnknown status
Fundación Investigación Clínico de Valencia
Coordinator of this site? Confirm its status
ValenciaSpainUnknown status
Instituto Nacional de Cancerologia
Coordinator of this site? Confirm its status
MéxicoMexicoUnknown status
VU Medical Centre
Coordinator of this site? Confirm its status
AmsterdamNetherlandsUnknown status
Institute of Pathology and Immunology of University of Porto
Coordinator of this site? Confirm its status
PortoPortugalUnknown status
GenPat
Coordinator of this site? Confirm its status
AsunciónParaguayUnknown status

This page is information, not medical advice. Discuss any trial with your doctor.